Walleye Trading’s Mesa Laboratories MLAB Stock Holding History

Walleye Trading’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-80	Closed	-$15K	–	5045
2018 Q3	$15K	Buy	+80	New	+$16.1K	﹤0.01%	4913

Other funds holding MLAB

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Walleye Trading's MLAB Position: Q4 2018 in Review

Walleye Trading sold out of Mesa Laboratories (MLAB) in Q4 2018, closing a stake of 80 shares — an estimated $15K sold.

Walleye Trading first reported a position in MLAB in Q3 2018 and held it in 1 quarter. The position peaked at $15K in Q3 2018. 109 funds tracked by Wall St. Rank hold MLAB as of Q4 2018.

Walleye Trading reported no remaining Mesa Laboratories position as of Q4 2018 after selling out during the quarter.
Walleye Trading sold 80 Mesa Laboratories shares in Q4 2018, an estimated $15K.
Walleye Trading first reported a position in Mesa Laboratories in Q3 2018 and held it in 1 quarter.
Walleye Trading's Mesa Laboratories position peaked at $15K in Q3 2018.
109 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2018.

Based on Walleye Trading's 13F filing for Q4 2018, filed 14 Feb 2019.